封面
市场调查报告书
商品编码
1762327

胎盘市场,规模,占有率,趋势,产业分析报告:类别,各用途,各地区,2025年~2034年的市场预测

Placenta Market Size, Share, Trends, Industry Analysis Report: By Type (Porcine, Equine, Ovine, and Others), Application, and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) - Market Forecast, 2025-2034

出版日期: | 出版商: Polaris Market Research | 英文 113 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究,预计到 2034 年,全球胎盘市场规模将达到 14.0487 亿美元。该报告深入分析了当前的市场动态,并分析了未来的市场成长。

胎盘组织及其萃取物在生殖医学中用于促进子宫健康、提高胚胎着床率并增强整体生育能力。接受体外受精 (IVF) 等辅助生殖技术 (ART) 的夫妇越来越多地选择基于胎盘的治疗来提高受孕几率。临床研究表明,胎盘萃取物中的生物活性化合物可以改善子宫内膜容受性,从而提高胚胎着床的成功率。由于生活方式改变、压力和受孕延迟等因素导致不孕不育率持续上升,对胎盘衍生不孕症治疗等创新解决方案的需求预计将增长。因此,胎盘在生育治疗的应用日益广泛,促进了胎盘市场的成长。

人们对胎盘在皮肤病学、毛髮学和生殖医学应用的认识不断提高,并持续刺激了需求。斑秃越来越普遍,尤其是在女性和某些种族中,这增加了对利用胎盘再生特性的先进疗法的需求。正在进行的科学研究正在增强胎盘产品的功效,扩大其在医疗和化妆品领域的应用。

随着医疗和化妆品行业对胎盘衍生产品的需求不断增长,胎盘市场正在迅速扩张。从抗衰老护肤到护髮和生育治疗,胎盘萃取物的应用正在推动创新和投资。人们对天然、科学支持的解决方案日益增长的偏好,刺激了对胎盘的需求。各公司不断开发新的配方,推动市场扩张。持续的进步使胎盘市场在美容、健康和保健行业中始终占据重要地位。

胎盘市场报告重点

按类型划分,由于猪胎盘用途广泛且易于获取,2024年猪胎盘占据了胎盘市场占有率的主导地位。猪胎盘因其富含胶原蛋白、蛋白质和活性胜肽,已成为市场上的宝贵资源。

按应用划分,预计製药领域在预测期内的复合年增长率最高。在製药领域,胎盘萃取物因其治疗特性而备受研究。其富含生长因子、细胞激素和细胞外囊泡等生物活性分子,使其成为治疗应用的有希望的候选材料。

由于对胎盘类化妆品、膳食补充剂和药品的需求不断增长等因素,北美在 2024 年占据了全球胎盘市场收入占有率的主导地位。

由于肌肉营养不良症等罕见疾病的盛行率上升以及对胎盘补充剂的需求不断增长,预计未来几年亚太市场将实现最高的复合年增长率。

第1章 简介

第2章 调查手法

第3章 摘要整理

第4章 市场洞察

  • 胎盘- 产业概述
  • 价值链分析
  • 胎盘市场动态
    • 促进因素和机会
      • 再生医学和伤口癒合领域的应用日益增多
      • 胎盘衍生产品创新发展生物製药
    • 限制与课题
      • 胎盘衍生产品开发成本高
  • 波特五力模型
    • 替代品的威胁:(中~高)
    • 新加入厂商业者的威胁:中~高
    • 从买方议价能力:中~高
    • 供给企业谈判力:(中)
    • 竞争企业间的敌对关係:高
  • 大环境分析

第5章 胎盘市场评估:类别

  • 简介
  • 绵羊
  • 其他

第6章 胎盘市场评估:各用途

  • 简介
  • 医药品
  • 化妆品
  • 补充品
  • 其他

第7章 胎盘市场评估:各地区

  • 简介
  • 北美胎盘市场
    • 各国
    • 类别
    • 美国的胎盘市场
    • 加拿大胎盘市场
  • 欧洲的胎盘市场
    • 各国
    • 类别
    • 各用途
    • 英国的胎盘市场
    • 法国的胎盘市场
    • 德国的胎盘市场
    • 义大利胎盘市场
    • 西班牙胎盘市场
    • 荷兰的胎盘市场
    • 俄罗斯的胎盘市场
    • 其他欧洲的胎盘市场
  • 亚太地区的胎盘市场
    • 各国
    • 类别
    • 各用途
    • 中国的胎盘市场
    • 日本胎盘市场
    • 韩国的胎盘市场
    • 印度的胎盘市场
    • 印尼的胎盘市场
    • 马来西亚的胎盘市场
    • 其他亚太地区的胎盘市场
  • 南美的胎盘市场
    • 各国
    • 类别
    • 各用途
    • 巴西的胎盘市场
    • 墨西哥胎盘市场
    • 阿根廷胎盘市场
    • 其他南美国家的胎盘市场
  • 中东及非洲的胎盘市场
    • 各国
    • 类别
    • 各用途
    • UAE胎盘市场
    • 以色列的胎盘市场
    • 沙乌地阿拉伯的胎盘市场
    • 南非的胎盘市场
    • 其他中东和非洲的胎盘市场

第8章 竞争情形

  • 策略性架构
  • 策略性架构
  • 业者情势
  • 最近的开发

第9章 企业简介

  • Japan Natural Laboratories Co., LTD.
  • Japan Bio Products Co. Ltd
  • ALBERT DAVID LIMITED
  • Atlanta Placenta Encapsulation
  • MIMEDX Group, Inc.
  • PURTIER Placenta
  • The Placenta Company
  • Smith+Nephew
  • Mommy made encapsulation
  • Nubloom LLC.
Product Code: PM3162

The global placenta market size is expected to reach USD 1,404.87 million by 2034, according to a new study by Polaris Market Research. The report "Placenta Market Size, Share, Trends, Industry Analysis Report: By Type (Porcine, Equine, Ovine, and Others), Application, and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Placental tissues and extracts are utilized in reproductive medicine to enhance uterine health, improve embryo implantation rates, and support overall fertility. Couples undergoing assisted reproductive technologies (ART), such as in-vitro fertilization (IVF), are increasingly turning to placenta-based treatments to enhance their chances of conception. Clinical research suggests that bioactive compounds found in placental extracts improve endometrial receptivity, making embryo implantation more successful. As infertility rates continue to rise due to factors such as lifestyle changes, stress, and delayed pregnancies, the need for innovative solutions such as placenta-derived fertility treatments is expected to grow. Thus, the expanding use of the placenta in fertility treatments is contributing to placenta market growth.

The rising awareness of placenta applications in dermatology, trichology, and reproductive medicine continues to fuel demand. With alopecia areata becoming more prevalent, particularly among women and certain ethnic groups, the need for advanced treatments utilizing the placenta's regenerative properties is growing. Ongoing scientific research is enhancing the effectiveness of placenta-based products, broadening their use across medical and cosmetic fields.

The placenta market is expanding rapidly as demand for placenta-derived products grows across the medical and cosmetic industries. From antiaging skincare to hair care and fertility treatments, the use of placental extracts is driving innovation and investment. The increasing preference for natural and scientifically backed solutions is fueling the placenta market demand. Companies are continuously developing new formulations, driving the market expansion. Ongoing advancements keep the market a significant player in the beauty, health, and wellness industries.

Placenta Market Report Highlights

Based on type, the porcine segment dominated the placenta market share in 2024 due to its versatility and availability of porcine placenta. Porcine (pig) placenta is emerging as a valuable resource in the market, owing to its rich composition of collagen, proteins, and bioactive peptides.

The pharmaceuticals segment, by application, is estimated to register the highest CAGR during the forecast period. In the pharmaceutical segment, placental extracts have been explored for their therapeutic properties. The rich composition of bioactive molecules such as growth factors, cytokines, and extracellular vesicles makes placental extracts promising candidates for therapeutic applications.

North America dominated the global placenta market revenue share in 2024 due to factors such as increasing demand for placenta-based cosmetics, health supplements, and pharmaceutical products.

The market in Asia Pacific is expected to register the highest CAGR in the coming years owing to rising prevalence of rare diseases such as muscular dystrophy and growing demand for placenta-based supplements.

A few global key market players are Japan Natural Laboratories Co., Ltd.; Japan Bio Products Co., Ltd.; Albert David Limited; Atlanta Placenta Encapsulation; MIMEDX Group, Inc.; PURTIER Placenta; The Placenta Company; Smith and Nephew; Mommy Made Encapsulation; and Nubloom LLC.

Polaris Market Research has segmented the placenta market report on the basis of type, application, and region:

By Type Outlook (Revenue, USD Million, 2020-2034)

Porcine

Equine

Ovine

Others

By Application Outlook (Revenue, USD Million, 2020-2034)

Pharmaceuticals

Cosmetics

Supplements

Others

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Russia

Italy

Spain

Netherlands

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

Israel

UAE

Rest of Middle East & Africa

Latin America

Brazil

Mexico

Argentina

Rest of Latin America

Table of Contents

Chapter 1. Introduction

  • 1.1 Report Description
    • 1.1.1 Objective of the Study
    • 1.1.2 Market Scope
    • 1.1.3 Assumptions
  • 1.2 Stakeholders

Chapter 2. Research Methodology

  • 2.1 Research Methodology
  • 2.2 Research Scope and Assumptions
  • 2.3 Information Procurement
    • 2.3.1 Purchased Database
    • 2.3.2 Internal Database
    • 2.3.3 Secondary Sources
    • 2.3.4 Third Party Perspective
    • 2.3.5 Primary Research
  • 2.4 Information Analysis
    • 2.4.1 Data Analysis Models
  • 2.5 Market Formulation and Data Visualization
  • 2.6 Data Validation and Publishing (Secondary Sources)

Chapter 3. Executive Summary

Chapter 4. Market Insights

  • 4.1 Placenta - Industry snapshot
  • 4.2 Placenta Market - Value Chain Analysis
  • 4.3 Placenta Market Dynamics
    • 4.3.1 Drivers and Opportunities
      • 4.3.1.1 Expanding Applications in Regenerative Medicine and Wound Healing
      • 4.3.1.2 Growing Placenta-Derived Biopharmaceutical Innovations
    • 4.3.2 Restraints and Challenges
      • 4.3.2.1 High Cost of Placenta-Based Product Development
  • 4.4 Placenta Market - Porter's Five Forces
    • 4.4.1 Threat of Substitutes: (Moderate to High)
    • 4.4.2 Threat of New Entrants: Moderate to High
    • 4.4.3 Bargaining power of buyers: Moderate to High
    • 4.4.4 Bargaining power of suppliers: Moderate
    • 4.4.5 Competitive Rivalry: High
  • 4.5 Placenta Market - PESTLE Analysis

Chapter 5. Placenta Market Assessment, By Type

  • 5.1 Introduction
  • 5.2 Porcine
  • 5.3 Equine
  • 5.4 Ovine
  • 5.5 Others

Chapter 6. Placenta Market Assessment, By Application

  • 6.1 Introduction
  • 6.2 Pharmaceuticals
  • 6.3 Cosmetics
  • 6.4 Supplements
  • 6.5 Others

Chapter 7. Placenta Market Assessment, By Region

  • 7.1 Introduction
  • 7.2 North America Placenta Market
    • 7.2.1 North America Placenta Market, By Country
    • 7.2.2 North America Placenta Market, By Type
      • 7.2.2.1 North America Placenta Market, By Application
    • 7.2.3 US Placenta Market
      • 7.2.3.1 US Placenta Market, By Type
      • 7.2.3.2 US Placenta Market, By Solutions
    • 7.2.4 Canada Placenta Market
      • 7.2.4.1 Canada Placenta Market, By Type
      • 7.2.4.2 Canada Placenta Market, By Application
  • 7.3 Europe Placenta Market
    • 7.3.1 Europe Placenta Market, By Country
    • 7.3.2 Europe Placenta Market, By Type
    • 7.3.3 Europe Placenta Market, By Application
    • 7.3.4 UK Placenta Market
      • 7.3.4.1 UK Placenta Market, By Type
      • 7.3.4.2 UK Placenta Market, By Application
    • 7.3.5 France Placenta Market
      • 7.3.5.1 France Placenta Market, By Type
      • 7.3.5.2 France Placenta Market, By Application
    • 7.3.6 Germany Placenta Market
      • 7.3.6.1 Germany Placenta Market, By Type
      • 7.3.6.2 Germany Placenta Market, By Application
    • 7.3.7 Italy Placenta Market
      • 7.3.7.1 Italy Placenta Market, By Type
      • 7.3.7.2 Italy Placenta Market, By Application
    • 7.3.8 Spain Placenta Market
      • 7.3.8.1 Spain Placenta Market, By Type
      • 7.3.8.2 Spain Placenta Market, By Application
    • 7.3.9 Netherlands Placenta Market
      • 7.3.9.1 Netherlands Placenta Market, By Type
      • 7.3.9.2 Netherlands Placenta Market, By Application
    • 7.3.10 Russia Placenta Market
      • 7.3.10.1 Russia Placenta Market, By Type
      • 7.3.10.2 Russia Placenta Market, By Application
    • 7.3.11 Rest of Europe Placenta Market
      • 7.3.11.1 Rest of Europe Placenta Market, By Type
      • 7.3.11.2 Rest of Europe Placenta Market, By Application
  • 7.4 Asia Pacific Placenta Market
    • 7.4.1 Asia Pacific Placenta Market, By Country
    • 7.4.2 Asia Pacific Placenta Market, By Type
    • 7.4.3 Asia Pacific Placenta Market, By Application
    • 7.4.4 China Placenta Market
      • 7.4.4.1 China Placenta Market, By Type
      • 7.4.4.2 China Placenta Market, By Application
    • 7.4.5 Japan Placenta Market
      • 7.4.5.1 Japan Placenta Market, By Type
      • 7.4.5.2 Japan Placenta Market, By Application
    • 7.4.6 South Korea Placenta Market
      • 7.4.6.1 South Korea Placenta Market, By Type
      • 7.4.6.2 South Korea Placenta Market, By Application
    • 7.4.7 India Placenta Market
      • 7.4.7.1 India Placenta Market, By Type
      • 7.4.7.2 India Placenta Market, By Application
    • 7.4.8 Indonesia Placenta Market
      • 7.4.8.1 Indonesia Placenta Market, By Type
      • 7.4.8.2 Indonesia Placenta Market, By Application
    • 7.4.9 Malaysia Placenta Market
      • 7.4.9.1 Malaysia Placenta Market, By Type
      • 7.4.9.2 Malaysia Placenta Market, By Application
    • 7.4.10 Rest of Asia Pacific Placenta Market
      • 7.4.10.1 Rest of Asia Pacific Placenta Market, By Type
      • 7.4.10.2 Rest of Asia Pacific Placenta Market, By Application
  • 7.5 Latin America Placenta Market
    • 7.5.1 Latin America Placenta Market, By Country
    • 7.5.2 Latin America Placenta Market, By Type
    • 7.5.3 Latin America Placenta Market, By Application
    • 7.5.4 Brazil Placenta Market
      • 7.5.4.1 Brazil Placenta Market, By Type
      • 7.5.4.2 Brazil Placenta Market, By Application
    • 7.5.5 Mexico Placenta Market
      • 7.5.5.1 Mexico Placenta Market, By Type
      • 7.5.5.2 Mexico Placenta Market, By Application
    • 7.5.6 Argentina Placenta Market
      • 7.5.6.1 Argentina Placenta Market, By Type
      • 7.5.6.2 Argentina Placenta Market, By Application
    • 7.5.7 Rest of Latin America Placenta Market
      • 7.5.7.1 Rest of Latin America Placenta Market, By Type
      • 7.5.7.2 Rest of Latin America Placenta Market, By Application
  • 7.6 Middle East and Africa Placenta Market
    • 7.6.1 Middle East and Africa Placenta Market, By Country
    • 7.6.2 Middle East and Africa Placenta Market, By Type
    • 7.6.3 Middle East and Africa Placenta Market, By Application
    • 7.6.4 UAE Placenta Market
      • 7.6.4.1 UAE Placenta Market, By Type
      • 7.6.4.2 UAE Placenta Market, By Application
    • 7.6.5 Israel Placenta Market
      • 7.6.5.1 Israel Placenta Market, By Type
      • 7.6.5.2 Israel Placenta Market, By Application
    • 7.6.6 Saudi Arabia Placenta Market
      • 7.6.6.1 Saudi Arabia Placenta Market, By Type
      • 7.6.6.2 Saudi Arabia Placenta Market, By Application
    • 7.6.7 South Africa Placenta Market
      • 7.6.7.1 South Africa Placenta Market, By Type
      • 7.6.7.2 South Africa Placenta Market, By Application
    • 7.6.8 Rest of Middle East & Africa Placenta Market
      • 7.6.8.1 Rest of Middle East & Africa Placenta Market, By Type
      • 7.6.8.2 Rest of Middle East & Africa Placenta Market, By Application

Chapter 8. Competitive Landscape

  • 8.1 Strategy Framework
  • 8.2 Strategy Framework
  • 8.3 Vendor Landscape
  • 8.4 Recent Development

Chapter 9. Company Profiles

  • 9.1 Japan Natural Laboratories Co., LTD.
    • 9.1.1 Business Overview
    • 9.1.2 Products Benchmarking
  • 9.2 Japan Bio Products Co. Ltd
    • 9.2.1 Business Overview
    • 9.2.2 Products Benchmarking
    • 9.2.3 Recent Developments
  • 9.3 ALBERT DAVID LIMITED
    • 9.3.1 Business Overview
    • 9.3.2 Financial Snapshot
      • 9.3.2.1 Total Income by Region
    • 9.3.3 Products Benchmarking
    • 9.3.4 Recent Developments
  • 9.4 Atlanta Placenta Encapsulation
    • 9.4.1 Business Overview
    • 9.4.2 Products Benchmarking
  • 9.5 MIMEDX Group, Inc.
    • 9.5.1 Business Overview
    • 9.5.2 Financial Snapshot
    • 9.5.3 Products Benchmarking
    • 9.5.4 Recent Developments
  • 9.6 PURTIER Placenta
    • 9.6.1 Business Overview
    • 9.6.2 Products Benchmarking
  • 9.7 The Placenta Company
    • 9.7.1 Business Overview
    • 9.7.2 Products and Services
  • 9.8 Smith+Nephew
    • 9.8.1 Business Overview
    • 9.8.2 Financial Snapshot
      • 9.8.2.1 Net Sales by Market Segment
    • 9.8.3 Products and Services
  • 9.9 Mommy made encapsulation
    • 9.9.1 Business Overview
    • 9.9.2 Products Benchmarking
  • 9.10 Nubloom LLC.
    • 9.10.1 Business Overview
    • 9.10.2 Products Benchmarking

List of Tables

  • Table 1 Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 2 Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 3 Placenta Market Assessment, By Geography, 2021 - 2034 (USD Million)
  • Table 4 North America Placenta Market, By Country, 2021 - 2034 (USD Million)
  • Table 5 North America Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 6 North America Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 7 US Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 8 US Placenta Market, By Solutions, 2021 - 2034 (USD Million)
  • Table 9 Canada Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 10 Canada Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 11 Europe Placenta Market, By Country, 2021 - 2034 (USD Million)
  • Table 12 Europe Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 13 Europe Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 14 UK Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 15 UK Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 16 France Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 17 France Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 18 Germany Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 19 Germany Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 20 Italy Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 21 Italy Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 22 Spain Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 23 Spain Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 24 Netherlands Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 25 Netherlands Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 26 Russia Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 27 Russia Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 28 Rest of Europe Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 29 Rest of Europe Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 30 Asia Pacific Placenta Market, By Country, 2021 - 2034 (USD Million)
  • Table 31 Asia Pacific Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 32 Asia Pacific Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 33 China Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 34 China Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 35 Japan Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 36 Japan Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 37 South Korea Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 38 South Korea Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 39 India Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 40 India Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 41 Indonesia Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 42 Indonesia Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 43 Malaysia Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 44 Malaysia Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 45 Rest of Asia Pacific Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 46 Rest of Asia Pacific Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 47 Latin America Placenta Market, By Country, 2021 - 2034 (USD Million)
  • Table 48 Latin America Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 49 Latin America Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 50 Brazil Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 51 Brazil Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 52 Mexico Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 53 Mexico Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 54 Argentina Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 55 Argentina Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 56 Rest of Latin America Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 57 Rest of Latin America Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 58 Middle East and Africa Placenta Market, By Country, 2021 - 2034 (USD Million)
  • Table 59 Middle East and Africa Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 60 Middle East and Africa Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 61 UAE Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 62 UAE Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 63 Israel Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 64 Israel Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 65 Saudi Arabia Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 66 Saudi Arabia Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 67 South Africa Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 68 South Africa Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 69 Rest of Middle East & Africa Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 70 Rest of Middle East & Africa Placenta Market, By Application, 2021 - 2034 (USD Million)

List of Figures

  • Figure 1. Information Procurement
  • Figure 2. Primary Research Pattern
  • Figure 3. Primary research process
  • Figure 4. Market research approaches - Bottom-Up Approach
  • Figure 5. Market research approaches - Top-Down Approach
  • Figure 6. Market research approaches - Combined Approach
  • Figure 7. Executive Summary
  • Figure 8. Market by Region, 2024 (USD Million)
  • Figure 9. Placenta Market, 2021 - 2034 (USD Million)
  • Figure 10. Value Chain Analysis
  • Figure 11. Porter's Five Forces
  • Figure 12. PESTLE Analysis
  • Figure 13. Market, By Type
  • Figure 14. Placenta Market, By Type, 2024 & 2034 (USD Million)
  • Figure 15. Placenta Market, By Porcine, 2021 - 2034 (USD Million)
  • Figure 16. Placenta Market, By Equine, 2021 - 2034 (USD Million)
  • Figure 17. Placenta Market, By Ovine, 2021 - 2034 (USD Million)
  • Figure 18. Placenta Market, By Others, 2021 - 2034 (USD Million)
  • Figure 19. Market, By Application
  • Figure 20. Placenta Market, By Application, 2024 & 2034 (USD Million)
  • Figure 21. Placenta Market, By Pharmaceuticals, 2021 - 2034 (USD Million)
  • Figure 22. Placenta Market, By Cosmetics, 2021 - 2034 (USD Million)
  • Figure 23. Placenta Market, By Supplements, 2021 - 2034 (USD Million)
  • Figure 24. Placenta Market, By Others, 2021 - 2034 (USD Million)
  • Figure 25. Placenta Market Assessment, By Geography, 2024 & 2034 (USD Million)